
Beijing Tiantan Biological Products Investor Relations Material
Latest events

Q1 2025
15 Apr, 2025

H2 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Beijing Tiantan Biological Products Co Ltd
Access all reports
Beijing Tiantan Biological Products Co., Ltd. is a biopharmaceutical company that develops, manufactures, and distributes a range of blood-based and vaccine products. The company focuses on producing plasma-derived products, including treatments for immune deficiencies and blood coagulation disorders, as well as vaccines for infectious diseases. Utilizing advanced bioprocessing and quality assurance standards, Beijing Tiantan Biological aims to support healthcare needs in China and potentially in international markets. The company is involved in research to expand its product portfolio within the biologics field. Beijing Tiantan Biological Products is headquartered in Beijing, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
600161
Country
🇨🇳 China